Down's syndrome fibroblasts exhibit enhanced inositol uptake

Area of Science:

• Biochemistry
• Cell Biology
• Genetics

Background:

• Down syndrome (DS), characterized by trisomy 21, presents with various cellular abnormalities.
• Inositol metabolism plays a crucial role in cellular functions, including phospholipid synthesis and membrane integrity.

Purpose of the Study:

• To investigate the inositol metabolism in skin fibroblasts from individuals with Down syndrome.
• To determine if trisomy 21 affects inositol uptake and its subsequent incorporation into cellular components.

Main Methods:

• Cultured skin fibroblasts from DS patients and controls (aneuploid and diploid).
• Measurement of [3H]inositol uptake using kinetic analysis.
• Assessed uptake of other metabolites like choline, serine, and glucose.
• Quantified incorporation of radiolabelled inositol into phospholipids.

Main Results:

• DS fibroblasts exhibited a 2-3 fold faster accumulation of [3H]inositol compared to controls.
• This enhanced uptake was attributed to an increased maximal velocity of high-affinity, Na(+)-dependent inositol transport.
• Trisomy 21 did not impact the uptake of choline, serine, or glucose.
• Increased inositol uptake correlated with a proportional rise in its incorporation into phospholipids.

Conclusions:

• Down syndrome cells display an altered inositol metabolism characterized by enhanced inositol transport.
• The increased inositol uptake and phospholipid incorporation suggest a potential role in DS-related plasma membrane abnormalities.
• Imbalances in inositol metabolism may be a contributing factor to the cellular phenotype of Down syndrome.